What is a stock summary page? Click here for an overview.
Business Description
GeneReach Biotechnology Corp
NAICS : 325411
ISIN : TW0004171004
Description
GeneReach Biotechnology Corp is a biotechnology company. The company develops, manufactures and markets products for applied nucleic acid detection technology. Its products are utilised for aquaculture, agriculture, food, companion animal, livestock and human health industries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.85 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | -7.52 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.98 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -40.7 | |||||
| 3-Year Book Growth Rate | -11.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.54 | |||||
| 9-Day RSI | 27.45 | |||||
| 14-Day RSI | 25.29 | |||||
| 3-1 Month Momentum % | -4.67 | |||||
| 6-1 Month Momentum % | -8.61 | |||||
| 12-1 Month Momentum % | -15.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.48 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 2.1 | |||||
| Days Inventory | 208.87 | |||||
| Days Sales Outstanding | 48.86 | |||||
| Days Payable | 5.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.01 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.28 | |||||
| Operating Margin % | -65.8 | |||||
| Net Margin % | -57.5 | |||||
| FCF Margin % | -15.35 | |||||
| ROE % | -15.25 | |||||
| ROA % | -10.39 | |||||
| ROIC % | -20.05 | |||||
| 3-Year ROIIC % | 289.24 | |||||
| ROC (Joel Greenblatt) % | -24.8 | |||||
| ROCE % | -12.3 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 16.75 | |||||
| PS Ratio | 5.11 | |||||
| PB Ratio | 1.47 | |||||
| Price-to-Tangible-Book | 1.5 | |||||
| EV-to-EBIT | -7.52 | |||||
| EV-to-EBITDA | -22.99 | |||||
| EV-to-Revenue | 4.04 | |||||
| EV-to-FCF | -25.89 | |||||
| Price-to-GF-Value | 0.89 | |||||
| Price-to-Projected-FCF | 0.69 | |||||
| Price-to-Median-PS-Value | 0.81 | |||||
| Price-to-Net-Current-Asset-Value | 4.31 | |||||
| Price-to-Net-Cash | 6.87 | |||||
| Earnings Yield (Greenblatt) % | -13.3 | |||||
| FCF Yield % | -3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneReach Biotechnology Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 206.488 | ||
| EPS (TTM) (NT$) | -2.07 | ||
| Beta | 0.48 | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 33.83 | ||
| 14-Day RSI | 25.29 | ||
| 14-Day ATR (NT$) | 0.995465 | ||
| 20-Day SMA (NT$) | 21.8875 | ||
| 12-1 Month Momentum % | -15.18 | ||
| 52-Week Range (NT$) | 15.4 - 38.15 | ||
| Shares Outstanding (Mil) | 57.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeneReach Biotechnology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeneReach Biotechnology Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeneReach Biotechnology Corp Frequently Asked Questions
What is GeneReach Biotechnology Corp(ROCO:4171)'s stock price today?
The current price of ROCO:4171 is NT$18.40. The 52 week high of ROCO:4171 is NT$38.15 and 52 week low is NT$15.40.
When is next earnings date of GeneReach Biotechnology Corp(ROCO:4171)?
The next earnings date of GeneReach Biotechnology Corp(ROCO:4171) is .
Does GeneReach Biotechnology Corp(ROCO:4171) pay dividends? If so, how much?
GeneReach Biotechnology Corp(ROCO:4171) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers